Medical News

RSS

Gene therapy and exercise may help sufferers of Lou Gehrig's disease

A new study in mice gives hope that a combination of gene therapy and exercise may extend the lives of people who have Lou Gehrig's disease.

15 Nov 2005

High alert as Taiwan finds highly pathogenic bird flu strain H7N3

According to officials in Taiwan they have found a highly pathogenic strain of avian flu, H7N3, in droppings left by a migratory bird.

14 Nov 2005

Blood pressure near the heart is more predictive of cardiovascular outcomes than blood pressure measured in the arm

Results from a new study show that amlodipine-based (calcium channel blocker) treatment is much more effective at reducing blood pressure near the heart than a conventional atenolol-based (beta blocker) regimen.

14 Nov 2005

FLT-1 blockers, cutting the legs of leukaemia

Leukaemia is characterised by an uncontrolled growth of abnormal blood cells in the bone marrow (BM).

14 Nov 2005

Seeing under the skin to reveal early signs of heart disease and stroke

A revolutionary diagnostic technique that sees under the skin sounds rooted in the realms of science fiction. But an invention akin to the Star Trek small handheld body scanner that shines light into the skin to detect early signs of heart disease and stroke could be on the market in less than two years.

14 Nov 2005

Bullying in schools - Are Victorian attitudes towards children partly to blame?

Professor Al Aynsley-Green, the new children's commissioner, has announced that tackling bullying in schools is his number one priority.

14 Nov 2005

Largest hepatitis-C U.S. study defines optimal therapy

Final results of the WIN-R trial,[1] the largest hepatitis C study conducted in U.S. patients, showed that weight-based REBETOL (ribavirin, USP) in combination therapy with PEG-INTRON (peginterferon alfa-2b) achieved significantly higher rates of sustained virologic response (SVR)[2] and lower rates of relapse compared to the combination therapy using a flat dose of ribavirin.

14 Nov 2005

Teenage suicides and Tamiflu - is there a link?

Roche the maker of the anti-flu drug Tamiflu has reported to authorities in Japan the possible suicides of two teenage boys although the company says there was no clear evidence that the drug had contributed to their deaths.

14 Nov 2005

China checking another possible case of human bird flu

According to the World Health Organisation (WHO), China is checking on a possible human case of bird flu in a northeastern province, the second part of the country to make such a precautionary diagnosis.

14 Nov 2005

Grandma was right all along, getting chilly can give you a cold

Welsh researchers have confirmed what your grandma always said was true that getting cold and chilly can give you a cold.

14 Nov 2005

Teenager died after having his lip pierced

At an inquest into his death the dangers of body piercing were underlined by a coroner following the death of the student from blood poisoning two months after having a ring put through his lip.

14 Nov 2005

"Luckiest man" - cured of AIDS - will have further tests

The British man thought to be the first person to have shaken off HIV, the virus that causes AIDS, is to undergo further clinical tests in the hope of a breakthrough in treating the condition.

14 Nov 2005

Doctors' surgeries open round the clock

In future patients in the UK will be able to see a GP in the evenings and at weekends.

14 Nov 2005

Warnings to be put on condoms

The U.S. Food and Drug Administration (FDA) is calling for warnings to be placed on condoms.

14 Nov 2005

Hospital liver transplant program suspended after 32 die waiting

Following reports in the media that a Southern California hospital had suspended its liver transplant program and had turned down scores of donor organs while 32 patients awaiting transplants had died, the facility has had it's certification of the liver transplant program revoked.

14 Nov 2005

Norvasc better than beta blockers for lowering blood pressure

According to a study presented at a meeting of the American Heart Association, Norvasc, was more effective at reducing blood pressure near the heart than standard, older treatments such as beta blockers.

14 Nov 2005

Edifoligide no better than placebo for clogged veins

A new drug, edifoligide, designed to prevent the clogging of veins used in coronary bypass surgery was no more effective than a placebo, according to the results of a Phase III clinical trial led by researchers at Duke Clinical Research Institute (DCRI).

14 Nov 2005